I also came across this article this morning, which is incredibly biased against Kazia, painting a picture that data from a "failed late-phase brain cancer trial" has been manipulated to "manufacture a path to FDA [approval]".
"Kazia Therapeutics has found a way to try to salvage a win from a failed late-phase brain cancer trial. By removing part of the control arm"
https://www.fiercebiotech.com/biotech/kazia-prunes-failed-brain-cancer-trial-dataset-manufacture-path-fda
I also came across this article this morning, which is...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)